ROYAL BANK OF CANADA - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$153,000
+350.0%
31,940
+294.0%
0.00%
Q2 2023$34,000
+17.2%
8,106
+52.3%
0.00%
Q1 2023$29,000
-46.3%
5,321
-37.5%
0.00%
Q4 2022$54,000
+80.0%
8,508
+198.2%
0.00%
Q3 2022$30,000
+114.3%
2,853
+15.3%
0.00%
Q2 2022$14,000
-68.2%
2,474
-47.6%
0.00%
Q1 2022$44,000
-24.1%
4,724
+25.7%
0.00%
Q4 2021$58,000
-12.1%
3,758
+36.3%
0.00%
Q3 2021$66,0002,7580.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$11,316,00014.13%
Memorial Sloan Kettering Cancer Center 674,196$16,093,00010.03%
PFM Health Sciences, LP 4,092,309$88,176,0002.59%
CloudAlpha Capital Management Limited/Hong Kong 305,000$7,280,0002.15%
Monashee Investment Management LLC 449,377$10,727,0001.98%
Avidity Partners Management LP 2,474,067$59,056,0001.31%
Green Alpha Advisors, LLC 32,836$784,0000.54%
Tekla Capital Management LLC 699,377$15,621,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 200,000$4,774,0000.40%
FARALLON CAPITAL MANAGEMENT LLC 2,963,448$70,738,0000.33%
View complete list of CARIBOU BIOSCIENCES INC shareholders